Company: SHPH
Filing Date: 2025-02-27
Form Type: 424B3
Source: 0001493152-25-008476
Chunk: 112

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-27
Form: 424B3
Chunk 112
---
 Warrants in proportion to the allocation of the proceeds. $0.7 million of legal and other fees are recorded as costs of the Public Offering and reduced the amount recorded to additional paid in capital, while less than $0.1 million of legal and other fees are recorded as expense.

Warrants

In connection with the January 2023 Alto Convertible Note, Boustead was granted warrants to purchase 8,909 shares of common stock, at an exercise price of $18.80 per share (Note 5). In addition, Alto was granted warrants to purchase 127,260 shares of common stock, at an exercise price of $0.48 per share, as adjusted (Note 5, 7).

In connection with the Convertible Bridge Notes issued on October 14, 2024, the lenders were granted warrants to purchase 240,917 shares of common stock, at an exercise price of $1.40 per share. In addition, in connection with the Convertible Bridge Notes issued on October 21, 2024, the lenders were granted warrants to purchase 88,544 shares of common stock, at an exercise price of $1.49 per share.

In connection with the October 2024 Equity Financing, the Company issued pre-funded warrants to purchase up to 2,555,246shares of common stock, at an exercise price of $0.001per share, and warrants to purchase up to 2,950,820shares of common stock, at an exercise price of $1.40per share. The table below excludes the pre-funded warrants, of which 729,246were exercised during the year ended December 31, 2024. As of December 31, 2024, 1,826,000pre-funded warrants remained unexercised and outstanding and have no expiration date.

| F-22 |

A summary of activity regarding warrants to purchase common stock (excluding pre-funded warrants) for the year ended December 31, 2024 were as follows:

Schedule of Warrants Activity

|                                |     | Number of 
 warrants  |           |     | Weighted Average 
 Exercise Price   |       |     | Average      
 Life (years) |      |
|:-------------------------------|:----|:----------|----------:|:----|:-----------------|------:|:----|:-------------|-----:|
| Outstanding, December 31, 2023 |     | $         |   184,000 |     | $